Skip to main content
Screener/Healthcare/Biotechnology

SNDX — Syndax Pharmaceuticals, Inc.

NASDAQ
$19.48+0.46 (+2.42%)
Small CapUnder $20HealthcareFastest GrowingLow Beta
$8.59
$25.59
$18.94
$20.37
EPS (TTM)$-2.80
P/E Ratio-6.41
Dividend Yield—
Market Cap$1.56B
Volume1.36M
Prev Close$19.04
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$64.9M-$42.7M$-0.4995.9%-65.8%
Q4 '25$68.5M-$68.0M$-0.78102.3%-99.3%
Q3 '25$45.9M-$60.7M$-0.7086.1%-132.4%
Q2 '25$38.0M-$71.8M$-0.8396.6%-189.3%
Q1 '25$20.0M-$84.8M$-0.9995.6%-423.3%
Q4 '24$7.7M-$94.2M$-1.10100.0%-1226.2%
Q3 '24$12.5M-$84.1M$-0.98100.0%-673.0%
Q2 '24$3.5M-$68.1M$-0.80100.0%-1944.7%
Get Your Daily Market Recap